Iconovo gr framsteg i utlicenseringsprocessen fr ICOpre - BioStock - Connecting Innovation and Capital
TNBI Stock | USD 0.02 0.01 33.33% |
Under 61% of Tanke Biosciences' investor base is looking to short. The analysis of overall sentiment of trading Tanke Biosciences pink sheet suggests that many investors are alarmed at this time. Tanke Biosciences' investing sentiment shows overall attitude of investors towards Tanke Biosciences.
Tanke |
Iconovo gr framsteg i utlicenseringsprocessen fr ICOpre BioStock - Connecting Innovation and Capital
Read at news.google.com
Tanke Biosciences Fundamental Analysis
We analyze Tanke Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tanke Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tanke Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Book Value Per Share
Book Value Per Share Comparative Analysis
Tanke Biosciences is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
Tanke Biosciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Tanke Biosciences pink sheet to make a market-neutral strategy. Peer analysis of Tanke Biosciences could also be used in its relative valuation, which is a method of valuing Tanke Biosciences by comparing valuation metrics with similar companies.
Peers
Tanke Biosciences Related Equities
ECGR | Bellatora | 6.67 |
| ||
AWCA | Awaysis Capital | 28.21 |
|
Complementary Tools for Tanke Pink Sheet analysis
When running Tanke Biosciences' price analysis, check to measure Tanke Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tanke Biosciences is operating at the current time. Most of Tanke Biosciences' value examination focuses on studying past and present price action to predict the probability of Tanke Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tanke Biosciences' price. Additionally, you may evaluate how the addition of Tanke Biosciences to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |